The aromatase inhibitor letrozole enhances the effect of doxorubicin and docetaxel in an MCF7 cell line model

<p>Introduction: Post-menopausal women with estrogen receptor (ER) positive breast cancer receive adjuvant chemotherapy and endocrine therapy sequentially since tamoxifen may antagonise the cytotoxicity of chemotherapy drugs. With increased use of aromatase inhibitors (...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Mary O’Neill, Fiona E.M. Paulin, Julie Vendrell, Clinton W. Ali, Alastair M. Thompson
Format: Artikel
Sprache:English
Veröffentlicht: Pensoft Publishers 2012-12-01
Schriftenreihe:BioDiscovery
Schlagworte:
Online Zugang:https://biodiscovery.pensoft.net/article/8940/download/pdf/